Saizen
Drug timelines are a Plus or Pro feature.
15 regulatory and trial events tracked for Saizen, covering 2010-06-22 to 2019-02-15. Get the full timeline:
Most recent: Clinical Trial Update: Efficacy and Safety Evaluation of Recombinant Human Growth Hormone (r-hGH), Saizen®, on a Population of Children With Hypochondroplasia, Treated at Least 3 Years or Until Near Final Height, When Applicable, in Comparison With a Historic Cohort of Non-treated Children [Phase 2]